FR4396M - - Google Patents

Info

Publication number
FR4396M
FR4396M FR14136A FR14136A FR4396M FR 4396 M FR4396 M FR 4396M FR 14136 A FR14136 A FR 14136A FR 14136 A FR14136 A FR 14136A FR 4396 M FR4396 M FR 4396M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR14136A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR14136A priority Critical patent/FR4396M/fr
Priority to BE677918D priority patent/BE677918A/fr
Application granted granted Critical
Publication of FR4396M publication Critical patent/FR4396M/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR14136A 1965-04-22 1965-04-22 Expired FR4396M (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR14136A FR4396M (es) 1965-04-22 1965-04-22
BE677918D BE677918A (es) 1965-04-22 1966-03-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR14136A FR4396M (es) 1965-04-22 1965-04-22

Publications (1)

Publication Number Publication Date
FR4396M true FR4396M (es) 1966-09-05

Family

ID=8576965

Family Applications (1)

Application Number Title Priority Date Filing Date
FR14136A Expired FR4396M (es) 1965-04-22 1965-04-22

Country Status (2)

Country Link
BE (1) BE677918A (es)
FR (1) FR4396M (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states

Also Published As

Publication number Publication date
BE677918A (es) 1966-09-01

Similar Documents

Publication Publication Date Title
JPS4829744B1 (es)
JPS4423916Y1 (es)
JPS4420022Y1 (es)
FR4396M (es)
JPS4413546Y1 (es)
JPS4519280Y1 (es)
JPS4328975Y1 (es)
BE675870A (es)
BE675659A (es)
BE673736A (es)
BE672809A (es)
BE672778A (es)
BE674791A (es)
BE672604A (es)
BE671675A (es)
SE307727B (es)
BE673686A (es)
BE672739A (es)
SE307244B (es)
NL6601356A (es)
BE671386A (es)
BE689547A (es)
BE678846A (es)
BE677535A (es)
BE675243A (es)